Characterising the tumour extracellular matrix (ECM) holds promise for identifying predictive biomarkers, particularly in assessing patient response to immunotherapy. While the cellular components of the tumour microenvironment have been extensively characterised, the non-cellular elements of this ecosystem remain underexplored. In this study,...
-
August 26, 2024 (v1)Conference paperUploaded on: October 16, 2024
-
May 8, 2008 (v1)Journal article
Background. The gene encoding cortactin, CTTN (locus 11q13), an actin-binding substrate of Src kinases, is frequently amplified in breast and head and neck squamous cell carcinomas (HNSCC) and cortactin overexpression is thought to contribute in a significant way to the invasive phenotype of these tumors. Elevated Epidermal Growth Factor...
Uploaded on: December 4, 2022 -
April 16, 2021 (v1)Journal article
The integrative analysis of tumor immune microenvironment (TiME) components, their interactions and their microanatomical distribution is mandatory to better understand tumor progression. Imaging Mass Cytometry (IMC) is a high dimensional tissue imaging system which allows the comprehensive and multiparametric in situ exploration of tumor...
Uploaded on: December 4, 2022 -
October 17, 2022 (v1)Journal article
Macrophages from human and mouse skin share phenotypic and functional features, but remain to be characterized in pathological skin conditions. Skinresident macrophages are known to derive from embryonic precursors or from adult hematopoiesis. In this report, we investigated the origins, phenotypes and functions of macrophage subsets in mouse...
Uploaded on: February 22, 2023 -
September 15, 2012 (v1)Journal article
PURPOSE: Intermediate/high-risk operated patients with head and neck cancer may benefit from the addition of EGF receptor (EGFR) inhibitor gefitinib to chemoradiation. This study was designed to assess improved outcomes and identify predictive biomarkers. EXPERIMENTAL DESIGN: Patients provided informed consent for tumor biomarker analyses and,...
Uploaded on: December 2, 2022 -
October 16, 2017 (v1)Journal article
Cellular fibronectin (FN) and tenascin-C (TNC) are prominent development-and disease-associated matrix components with pro-and anti-adhesive activity, respectively. Whereas both are present in the tumour vasculature, their functional interplay on vascular endothelial cells remains unclear. We have previously shown that basally-oriented...
Uploaded on: February 28, 2023 -
October 2021 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
December 2018 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
January 19, 2017 (v1)Journal article
Functional interplay between tumour cells and their neoplastic extracellular matrix plays a decisive role in malignant progression of carcinomas. Here we provide a comprehensive data set of the human HNSCC-associated fibroblast matrisome. Although much attention has been paid to the deposit of collagen, we identify oncofetal fibronectin (FN) as...
Uploaded on: December 3, 2022 -
2020 (v1)Journal article
Background: Adenoid cystic carcinoma (ACC) accounts for 1% of malignant head and neck tumours [1] and 10% of salivary glands malignant tumours. The main objective of our study is to investigate the prognostic factors influencing the event-free survival (EFS) of patients with ACC. Patients and methods: A multicentre prospective study was...
Uploaded on: December 3, 2022 -
January 1, 1970 (v1)Journal article
Although Human Papilloma Virus (HPV)-driven oropharyngeal cancer (OPC) prognosis is significantly better than that of other head and neck cancers, up to 25% of cases will recur within 5 years. Data on the pattern of disease recurrence and efficiency of salvage treatment are still sparse.Material and method: Observational study of all recurrent...
Uploaded on: December 3, 2022 -
January 2021 (v1)Journal article
Background: The aim of this study was to assess the impact of the initial therapeutic strategy on oncologic outcomes in patients with HPV-positive OPSCC.Methods: All p16-positive OPSCCs treated from 2009 to 2014 in 7 centers were retrospectively included and classified according to the therapeutic strategy: surgical strategy (surgery ± adjuvant...
Uploaded on: December 4, 2022 -
January 2021 (v1)Journal article
Patients with oropharyngeal squamous cell carcinoma (OPSCC) display a significant risk of synchronous primary neoplasia (SPN) which could impact their management. The aims of this study were to evaluate the risk and distribution of SPN in OPSCC patients according to their HPV (p16) status, the predictive factors of SPN and the impact of SPN on...
Uploaded on: December 3, 2022 -
November 2021 (v1)Journal article
Introduction: Patients with oropharyngeal squamous cell carcinoma (OPSCC) display a significant risk to develop a metachronous second primary neoplasia (MSPN). HPV and non-HPV-related OPSCC are 2 distinct entities with biological, clinical and prognostic differences. The aims of our study were to analyze the impact of tumor HPV status and other...
Uploaded on: December 3, 2022 -
February 2021 (v1)Journal article
Therapeutic management of oropharyngeal squamous cell carcinomas (OPSCC) is still debated. Since the role of HPV was demonstrated, few studies have focused on HPV-negative OPSCC. The aim of our study was to assess the impact of therapeutic strategy (surgical vs. non-surgical) on oncologic outcomes in patients with HPV-negative OPSCC.Material...
Uploaded on: December 3, 2022